WunderGlo Foundation provides funding for Colorectal Cancer Research, paper published in Molecular Cancer Therapeutics
WunderGlo Foundation provides funding for Colorectal Cancer Research, paper published in Molecular Cancer Therapeutics
October 2015
The WunderGlo Foundation has given $750,000 directly to Research for THE CURE of CRC and in four short years as an organization, we have given over $800,000 in CRC research funding.
“Another paper published, thanks to WunderGlo for funding this important research.” –Dr. Lenz
Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer, Molecular Cancer Therapeutics, 2015